Stock listing

BX Swiss:MEDCL MedinCell SA Aktie

Swiss listing (BX Swiss) of MedinCell SA · home listing Euronext:MEDCL

Follow MedinCell SA into a list and get an email when it puts out news.

Home listing price · EURONEXT:MEDCL

€25.72 EUR -0.60 (-2.3%)

Close on Oct 16, 2026 · This listing has no price on 6ix; the price shown is the home listing's, EURONEXT:MEDCL

Since Jul 6, 2026 -9.7% · daily closes, Jul 6, 2026 – Oct 16, 2026, adjusted for splits
Day range
€25.60 – €26.90 EUROct 16, 2026
Volume
114,435 sharesOct 16, 2026
Market value
€923.9M EURAt the close on Oct 16, 2026 · price × 35.92M shares outstanding
MedinCell SA logo
Ticker
BX Swiss:MEDCL
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
BX Swiss
Currency
CHF

What changed lately

Calls

Replays

  • Medincell (Euronext:MEDCL) Q2 2026 Earnings Call

    Tue, Dec 09, 2025 · 1:00 PM ET

    Watch Transcript

  • Medincell (Euronext:MEDCL) Q4 2021 Earnings Call

    Tue, Jun 14, 2022 · 8:30 PM ET

    Watch Transcript

  • Medincell (Euronext:MEDCL) Q2 2021 Earnings Call

    Tue, Dec 07, 2021 · 8:30 PM ET

    Watch Transcript

Latest news

Medincell Announces New Publication Date for Its Half-Year Financial Result (April 1st – September 30, 2026)

Oct 14, 2026

Medincell Brings Total Non-Dilutive Financing Secured Since July 2026 to €41.8 Million with an Additional €13.8 Million Loan

Oct 13, 2026

Medincell Announces Resumption of Trading in Its Shares on Euronext Paris as of 2: 45pm

Oct 9, 2026

Medincell Achieves Major Milestone with U.S. FDA Approval of WELTRUZA™ (olanzapine)

Oct 9, 2026

Medincell prolongation exceptionnelle de la période de vote par correspondance pour l’Assemblée Générale jusqu'à 15h00 aujourd'hui

Sep 30, 2026

Medincell Extends Remote Voting Deadline for its Annual General Meeting Until 3: 00 p.m. Today

Sep 30, 2026

Medincell to Participate in Upcoming Investor Conferences

Sep 9, 2026

Medincell: Publication of the Notice of Meeting and Reminder of the Participation terms in the Combined General Meeting

Sep 8, 2026

Medincell Appoints Edna Venneker, MD, as Chief Medical Officer

Sep 1, 2026

Medincell: UZEDY®: Record Q2 Net Sales of $77M, Up 43% YoY; Teva Raises 2026 Outlook

Jul 29, 2026

All MedinCell SA news

Decks

MedinCell SA on 6ix

Sector
Health care
Industry
Biotechnology
News releases
40 in the last 12 months · 54 in all · newest Oct 14, 2026 · oldest 2025
Calls
3 calls with a replay · 3 with a transcript · latest Dec 9, 2025
Decks
8 decks · latest Dec 9, 2025

Where MedinCell SA is listed

ListingExchangeCountryCurrency
Euronext:MEDCL · Home listingEuronextFranceEUR
gettex:MEBgettexGermanyEUR
LSE:0ACHLSEUnited KingdomEUR
Tradegate:MEBTradegateGermanyEUR
LS Exchange:A2N6VALS ExchangeGermanyEUR
Lang & Schwarz:A2N6VALang & SchwarzGermanyEUR
OTC:MDCLFOTCUnited StatesUSD
Frankfurt:MEBFrankfurtGermanyEUR
BX Swiss:MEDCL · This pageBX SwissSwitzerlandCHF
Turquoise:MEDCLPTurquoiseUnited KingdomEUR
Hamburg:MEBHamburgGermanyEUR
Stuttgart:MEBStuttgartGermanyEUR
Aquis:MEDCLPAquisUnited KingdomEUR
Aquis:MEDCLPAquisUnited KingdomEUR
Dusseldorf:MEBDusseldorfGermanyEUR
Munich:MEBMunichGermanyEUR

Log in to ask 6ix AI your own questions about MedinCell SA.